<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/80392F0C-23A4-449D-BC8D-4D77C0F53303"><gtr:id>80392F0C-23A4-449D-BC8D-4D77C0F53303</gtr:id><gtr:name>Mahidol University</gtr:name><gtr:address><gtr:line1>Mahidol University</gtr:line1><gtr:line2>Office of the President  Mahidol Univers</gtr:line2><gtr:line3>25/25 Moo 3, Phuttamonthon 4 Road</gtr:line3><gtr:postCode>73170</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/80392F0C-23A4-449D-BC8D-4D77C0F53303"><gtr:id>80392F0C-23A4-449D-BC8D-4D77C0F53303</gtr:id><gtr:name>Mahidol University</gtr:name><gtr:address><gtr:line1>Mahidol University</gtr:line1><gtr:line2>Office of the President  Mahidol Univers</gtr:line2><gtr:line3>25/25 Moo 3, Phuttamonthon 4 Road</gtr:line3><gtr:postCode>73170</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F0DDF24E-7698-449D-BF5C-2B2BB0DD500A"><gtr:id>F0DDF24E-7698-449D-BF5C-2B2BB0DD500A</gtr:id><gtr:firstName>Gavin</gtr:firstName><gtr:otherNames>Robert</gtr:otherNames><gtr:surname>Screaton</gtr:surname><gtr:orcidId>0000-0002-3549-4309</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400720"><gtr:id>948CBF6A-25B6-4CD9-96DF-450442E5C9D3</gtr:id><gtr:title>Death receptors and immune function in health and disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400720</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Programmed cell death or apoptosis is a key biological process which underlies the developmental restructuring and modelling which occurs during embryogenesis. Apoptosis is also involved in the function and homeostasis of a variety of biological systems. This is perhaps most clearly illustrated in the immune system where apoptosis governs many aspects of development, homeostasis and function. Recently alterations in the expression of apoptosis inducing proteins have been shown to play an important role in disease pathogenesis. In the laboratory we have built a platform consisting of techniques, reagents to study the role of apoptosis in normal immune function and also begun to study potential links between apoptosis and disease.
 
In the first part of this Senior Fellowship Death receptors and immune function in health and disease investigations on several aspects of apoptosis signalling and regulation have yielded interesting results which include: structure of complex between TRAIL and Death Receptor 5, members of the TNF and TNF receptor protein superfamiles; study of the role of CD8 signalling in lymphocyte apoptosis and study the role of another TNF family member. Fas Ligand (FasL), in tumour rejection/immunity. By further study of observations made in the first phase of this Senior Fellowship we hope to develop technologies to manipulate or exploit the apoptotic program for the treatment of human disease. This application proposes an ambitious program of investigation which will form the central research theme for the lab over the next five years. Although far reaching the additional manpower available in the lab should make it possible to achieve the stated aims within the proposed timeframe. The three lines of investigation are detailed below: 1. Structural studies of TNF/TNF receptor interactions. 2.Development of strategies to specifically target auto-reactive T cell populations. 3.Further study of Fas ligand and tumour immunity with the aim of developing new therapeutic strategies.</gtr:technicalSummary><gtr:fund><gtr:end>2009-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>960990</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Felix Rey</gtr:description><gtr:id>E09C638A-AC76-4644-9F80-0D66B2623F52</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>dbp9hGbaPa9-1</gtr:outcomeId><gtr:partnerContribution>Felix Rey at Pasteur solves the structures of antibodies bound to dengue antigens</gtr:partnerContribution><gtr:piContribution>We make monoclonal antibodies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mahidol University</gtr:collaboratingOrganisation><gtr:country>Thailand, Kingdom of</gtr:country><gtr:department>Siriraj Hospital</gtr:department><gtr:description>Dengue clinical centres</gtr:description><gtr:id>F740138E-F23D-4B2B-9EFB-F54FA1356D24</gtr:id><gtr:impact>publications</gtr:impact><gtr:outcomeId>hf6c7vsEapZ-1</gtr:outcomeId><gtr:partnerContribution>Sample collection and processing</gtr:partnerContribution><gtr:piContribution>We get our samples from Thailand to measure biomarkers</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description> Staff Rounds</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>79B91D7E-0F20-4E7B-B284-54F20ACA0D95</gtr:id><gtr:impact>About 80 health professionals attend these rounds weekly. The presentations are given by different divisions each week and highlight the latest trends in medicine.

Keeping abrest with the latest in medicine and continued professional development.</gtr:impact><gtr:outcomeId>a3X444UoNM4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Society for Immunology Congress 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2BE4719A-3C52-44F2-A53C-7891BB38012A</gtr:id><gtr:impact>British Society for Immunology Congress 2013 in Liverpool from 2nd to 5th December. Title was &amp;quot;Protective and pathogenic immunity in dengue virus infection&amp;quot;.

Generated interest.</gtr:impact><gtr:outcomeId>kfTpUTBHW5T</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.bsicongress.com</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Congress on Medical Virology 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3AED99DC-4FC3-4E6E-AF99-8D82BD2C07D1</gtr:id><gtr:impact>I lectured on protective and pathogenic immunity in dengue virus infection and it sparked questions.

N.A.</gtr:impact><gtr:outcomeId>5461ee65b430a1.61457450</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.icmv2014.com/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview With BBC</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>89F907F1-5DBF-49DF-BDE0-CC2FAD7DE784</gtr:id><gtr:impact>Spread of Knowledge on Dengue

Higher interest Dengue Virus and more awareness</gtr:impact><gtr:outcomeId>iVWPpqqNnrF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grants</gtr:description><gtr:end>2007-04-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>482D7C04-611E-4F6B-954D-A7112B0621E4</gtr:id><gtr:outcomeId>DA18276F9820</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2004-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Investigator</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>0E31AA9E-BCAD-4A9E-AA16-6AC3C149B1FA</gtr:id><gtr:outcomeId>M5oNp9Vr6ZW</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomarkers grant</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>3D99C5A8-D69F-4D14-B1B2-14DD595B828F</gtr:id><gtr:outcomeId>4574A29CD1C0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO committee on dengue prevention and control</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>93F32CF2-0871-406E-B1D6-E31AB7BEC208</gtr:id><gtr:outcomeId>D25D8D6E4D5</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>World Innovation Summit for Health</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>2E0922ED-2A7B-499B-BDDA-E139EB48727E</gtr:id><gtr:outcomeId>KdgX6Gar6nP</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Wellcome Centre for Clinical Tropical Medicine/Global Health Research annual meeting 2013</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>62C12C5E-A4D9-434C-AFAD-7C992B29F78E</gtr:id><gtr:impact>Understanding Dengue pathogenesis and prospects for vaccine</gtr:impact><gtr:outcomeId>QNy9rGugwKd</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>HVBD DART 2013 First International Symposium on Human Vector-Borne Diseases Satellite Symposium</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E9474714-1453-432A-AEFF-C828FA497263</gtr:id><gtr:outcomeId>dgkoNnnTJ6h</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0DD09F66-46B9-4109-BD4A-32090BFD9092</gtr:id><gtr:title>Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10ed0f78d99370f902a6926e13983a6b"><gtr:id>10ed0f78d99370f902a6926e13983a6b</gtr:id><gtr:otherNames>Midgley CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56dd63e4d45fa0.05128927</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD027DF1-14CA-43C9-A364-30DE3B540079</gtr:id><gtr:title>HIV-1 down-regulates the expression of CD1d via Nef.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3919cff5936bc67a9455761d5e83401"><gtr:id>f3919cff5936bc67a9455761d5e83401</gtr:id><gtr:otherNames>Chen N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>56dd649d1d10b2.85683344</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B607F27-16EE-4330-AC3E-89434142BF50</gtr:id><gtr:title>Recognition determinants of broadly neutralizing human antibodies against dengue viruses.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c031b5eaaf37d25bcbf7f60664e712c"><gtr:id>6c031b5eaaf37d25bcbf7f60664e712c</gtr:id><gtr:otherNames>Rouvinski A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56dd60cc30b388.06877781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F196544-8F41-4979-B28A-8A0B07A33D05</gtr:id><gtr:title>Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1383435e43602a50e492d78c4647d72"><gtr:id>d1383435e43602a50e492d78c4647d72</gtr:id><gtr:otherNames>Dejnirattisai W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>58ac546fd66961.05829339</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E9C92EB-261E-4BA3-9ED5-800CE7FCDBB9</gtr:id><gtr:title>Enhanced immune recognition of cryptic glycan markers in human tumors.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e332ac0a0bc0f21fb78d7d529aa2302"><gtr:id>7e332ac0a0bc0f21fb78d7d529aa2302</gtr:id><gtr:otherNames>Newsom-Davis TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>56dd63e6206145.30448231</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D41B7E5B-C3C5-4B20-B61E-46167AE41517</gtr:id><gtr:title>Ig-like transcript 4 inhibits lipid antigen presentation through direct CD1d interaction.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70757d4f43d859ae837579a97bdeb00f"><gtr:id>70757d4f43d859ae837579a97bdeb00f</gtr:id><gtr:otherNames>Li D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56dd649bbae8b7.07625414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1646B8A7-90BA-4CF4-9561-FACBC36BF25A</gtr:id><gtr:title>High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fca4d2dc6e8382637b27d16998739126"><gtr:id>fca4d2dc6e8382637b27d16998739126</gtr:id><gtr:otherNames>Tsai WY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>56dd62fdd6f869.95215043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D5FCE65-149D-4C4E-9F5E-33200379D5EE</gtr:id><gtr:title>Recent advances in understanding dengue.</gtr:title><gtr:parentPublicationTitle>F1000Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1ac033a4df3945c2f4707dddd3643e8"><gtr:id>c1ac033a4df3945c2f4707dddd3643e8</gtr:id><gtr:otherNames>Yacoub S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2046-1402</gtr:issn><gtr:outcomeId>58ac540b700634.69609494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04D516FC-C1B1-41BF-897E-DCC9157C0142</gtr:id><gtr:title>Remarkably low affinity of CD4/peptide-major histocompatibility complex class II protein interactions.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f35343efd6a5a8ddc873888ac57c309d"><gtr:id>f35343efd6a5a8ddc873888ac57c309d</gtr:id><gtr:otherNames>J?nsson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58ac54266de312.88032098</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F66739D-DAAF-4BC5-BA81-0CAACD0BC260</gtr:id><gtr:title>Following a TRAIL: update on a ligand and its five receptors.</gtr:title><gtr:parentPublicationTitle>Cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3eccc39787aa628a052ab987c0c3b99"><gtr:id>b3eccc39787aa628a052ab987c0c3b99</gtr:id><gtr:otherNames>Kimberley FC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1001-0602</gtr:issn><gtr:outcomeId>56dd649db1b5d9.15681741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C96AC63C-71C4-4776-B305-4571C341D62F</gtr:id><gtr:title>An in-depth analysis of original antigenic sin in dengue virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10ed0f78d99370f902a6926e13983a6b"><gtr:id>10ed0f78d99370f902a6926e13983a6b</gtr:id><gtr:otherNames>Midgley CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>56dd63e555c1c3.22079032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>385BD679-24E5-4312-9611-A3F340DDFE29</gtr:id><gtr:title>Association of Microvascular Function and Endothelial Biomarkers With Clinical Outcome in Dengue: An Observational Study.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1ac033a4df3945c2f4707dddd3643e8"><gtr:id>c1ac033a4df3945c2f4707dddd3643e8</gtr:id><gtr:otherNames>Yacoub S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>58ac546f36f1a8.06272366</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDC10B3B-A56D-4BB7-BE15-6E6222BFF362</gtr:id><gtr:title>Expression of TRAIL and TRAIL receptors in normal and malignant tissues.</gtr:title><gtr:parentPublicationTitle>Cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/173e012f1282a332dbe24334563ced2f"><gtr:id>173e012f1282a332dbe24334563ced2f</gtr:id><gtr:otherNames>Daniels RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1001-0602</gtr:issn><gtr:outcomeId>56dd649d69d095.76672313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE12EC7A-99FE-40D5-8C15-55B38CD560E0</gtr:id><gtr:title>Generation of tumour-rejecting anti-carbohydrate monoclonal antibodies using melanoma modified with Fas ligand.</gtr:title><gtr:parentPublicationTitle>International immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e067e8d445dbbd31448cdcc2eda5fa95"><gtr:id>e067e8d445dbbd31448cdcc2eda5fa95</gtr:id><gtr:otherNames>Simon AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0953-8178</gtr:issn><gtr:outcomeId>56dd649c33e8c2.58881435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD7170D6-4010-4689-8214-C416E39CCCA2</gtr:id><gtr:title>The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39de87038ef33f889085a8a3b58da060"><gtr:id>39de87038ef33f889085a8a3b58da060</gtr:id><gtr:otherNames>Freundt EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>56dd63e583fa94.33992116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BAF754B-DC26-48E1-B130-A1A7F3CC14E4</gtr:id><gtr:title>A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1383435e43602a50e492d78c4647d72"><gtr:id>d1383435e43602a50e492d78c4647d72</gtr:id><gtr:otherNames>Dejnirattisai W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>56dd62639a6963.47103676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D83C64C-E7E7-4EAC-B940-8D844DB251F9</gtr:id><gtr:title>Sensing of immature particles produced by dengue virus infected cells induces an antiviral response by plasmacytoid dendritic cells.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af15431fa34ac896e6a43fdb8ac4c9ed"><gtr:id>af15431fa34ac896e6a43fdb8ac4c9ed</gtr:id><gtr:otherNames>D?cembre E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>56dd62af2a0ce1.83055223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84C1F045-A887-49BF-902B-119B86AA09C7</gtr:id><gtr:title>Structural flexibility of the macrophage dengue virus receptor CLEC5A: implications for ligand binding and signaling.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36299e25d361f3a506a3aa377ee12437"><gtr:id>36299e25d361f3a506a3aa377ee12437</gtr:id><gtr:otherNames>Watson AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56dd63e50ecb72.11467982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5BF733C-FBBD-4389-8D5A-EFD73C2AE252</gtr:id><gtr:title>Antibodies and tuberculosis.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8f652ecc13085fce6584f220c0089a9"><gtr:id>d8f652ecc13085fce6584f220c0089a9</gtr:id><gtr:otherNames>Jacobs AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>58b6e5883e83a1.08237717</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C28F1DE0-D9A0-4ACD-8D0A-DC5966010038</gtr:id><gtr:title>Structural basis of potent Zika-dengue virus antibody cross-neutralization.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6be8fbe643ad7e1ee8e12b8c197087fb"><gtr:id>6be8fbe643ad7e1ee8e12b8c197087fb</gtr:id><gtr:otherNames>Barba-Spaeth G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>58ac546fa524b1.82315031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44DDD1E3-30CF-466B-B5A6-16B63EED48CA</gtr:id><gtr:title>Synovial IL-21/TNF-producing CD4T cells induce joint destruction in rheumatoid arthritis by inducing matrix metalloproteinase production by fibroblast-like synoviocytes.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d93e20bb653711bec5e0ee4ed73e3839"><gtr:id>d93e20bb653711bec5e0ee4ed73e3839</gtr:id><gtr:otherNames>Lebre MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>58b6e587e26a58.38300852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12B1C667-32D3-4EDF-A476-BA610B5BD45E</gtr:id><gtr:title>A novel CD45 transcript involving the alternative splicing of a new exon is widely distributed in lymphoid tissues.</gtr:title><gtr:parentPublicationTitle>Human immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70757d4f43d859ae837579a97bdeb00f"><gtr:id>70757d4f43d859ae837579a97bdeb00f</gtr:id><gtr:otherNames>Li D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0198-8859</gtr:issn><gtr:outcomeId>56dd649d916351.33100568</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23BCBE9F-849A-4443-A1EB-046F5CF5D301</gtr:id><gtr:title>Microvascular and endothelial function for risk prediction in dengue: an observational study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1ac033a4df3945c2f4707dddd3643e8"><gtr:id>c1ac033a4df3945c2f4707dddd3643e8</gtr:id><gtr:otherNames>Yacoub S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>58ac537fbb75f8.47832090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A730DB20-6631-4A4A-9483-9EC6A98A2D84</gtr:id><gtr:title>Complement alternative pathway genetic variation and Dengue infection in the Thai population.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/386eedd87061ad6154faa3f4aa3eb0a8"><gtr:id>386eedd87061ad6154faa3f4aa3eb0a8</gtr:id><gtr:otherNames>Kraivong R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>56dd62fe0e1749.96889418</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BADC6DE-0B48-435E-9420-20A8E062DE1B</gtr:id><gtr:title>MAIT cells are activated during human viral infections.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd9c5d3ad67e5b8adc8f4409ebdea785"><gtr:id>fd9c5d3ad67e5b8adc8f4409ebdea785</gtr:id><gtr:otherNames>van Wilgenburg B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58ac546f70bc37.78204478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71273561-3CCA-49D5-BDA6-1800635D0C06</gtr:id><gtr:title>Falling into TRAPS--receptor misfolding in the TNF receptor 1-associated periodic fever syndrome.</gtr:title><gtr:parentPublicationTitle>Arthritis research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3eccc39787aa628a052ab987c0c3b99"><gtr:id>b3eccc39787aa628a052ab987c0c3b99</gtr:id><gtr:otherNames>Kimberley FC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1478-6354</gtr:issn><gtr:outcomeId>56dd649c897535.36329193</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400720</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>